Northwestern University is leveraging its world-renowned biomedical research enterprise to better understand and defeat cancer. Bringing engineering, chemistry, computer science and physics to the fight against cancer, Northwestern’s interdisciplinary research groups are collaborating to develop new technologies and innovative drug delivery methods to detect and treat cancer earlier and more effectively. By digging deep into the basic science of cancer, Northwestern aims to drastically reduce cancer mortality, cut treatment costs, and revolutionize cancer research and drug discovery across the globe.
Media Relations Contacts
Amanda Morris, Writer/Media Relations Specialist
Megan Fellman, Senior Editor, Public Relations
Meet Our Experts
View bios, quotes and downloadable images.
- Vadim Backman Vadim Backman is a biomedical engineer whose lab is focused on the development of nanoscale imaging techniques for non-invasive screening, diagnosis and detection of disease, as well as research on the physical mechanisms regulating genomic events in early carcinogenesis.
- Thomas O'Halloran Thomas O'Halloran is a chemist focused on how living cells sense, regulate and manage metals, and how the levels of some metals within cells may play a role in infectious diseases, cancer, liver disorders and diabetes.
- Neil Kelleher Neil Kelleher is a molecular bioscientist working in top-down proteomics, chromatin biology, and the biosynthesis and discovery of novel natural products with potential pharmacological activities.
- Lifang Hou Lifang Hou is a population scientist who integrates traditional epidemiological methods with cutting-edge molecular techniques to identify key molecular markers and understand their role in disease.